Botryosphaeran Attenuates Tumor Development and the Cancer Cachexia Syndrome in Walker-256 Tumor-Bearing Obese Rats and Improves the Metabolic and Hematological Profiles of These Rats-Reference-Cited by-同舟云学术

Botryosphaeran Attenuates Tumor Development and the Cancer Cachexia Syndrome in Walker-256 Tumor-Bearing Obese Rats and Improves the Metabolic and Hematological Profiles of These Rats

Published:2020-07-08 Issue:7 Volume:73 Page:1175-1192
ISSN:0163-5581
Container-title:Nutrition and Cancer
language:en
Short-container-title:Nutrition and Cancer

Author:

Comiran Patrícia K.¹,Ribeiro Mariana C.¹,Silva John H. G.¹,Martins Kamila O.¹,Santos Izabella A.¹,Chiaradia Ana Emilia F.¹,Silva Amadeu Z.¹,Dekker Robert F. H.²^ORCID,Barbosa-Dekker Aneli M.³^ORCID,Alegranci Pâmela¹^ORCID,Queiroz Eveline A. I. F.¹^ORCID

Affiliation:

1. Núcleo de Pesquisa e Apoio Didático em Saúde (NUPADS), Instituto de Ciências da Saúde, Câmpus Universitário de Sinop, Universidade Federal de Mato Grosso, Sinop, MT, Brazil

2. Programa de Pós-Graduação em Engenharia Ambiental, Universidade Tecnológica Federal do Paraná, Londrina, PR, Brazil

3. Departamento de Química - CCE, Universidade Estadual de Londrina, Londrina, PR, Brazil CEP

Publisher

Informa UK Limited

Subject

Cancer Research,Nutrition and Dietetics,Oncology,Medicine (miscellaneous)

Link

https://www.tandfonline.com/doi/pdf/10.1080/01635581.2020.1789681

Reference64 articles.

1. World Health Organization. Câncer. [Accessed 2018 Nov]. https://www.who.int/news-room/fact-sheets/detail/cancer.

2. The most important questions in cancer research and clinical oncology—Question 2–5. Obesity-related cancers: more questions than answers

3. Insulin Receptor Isoforms in Cancer

4. World Health Organization. Obesity and overweight. [Accessed 2018 Nov]. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revisiting and proposing the most important questions in cancer research and clinical oncology;Visualized Cancer Medicine;2024

2. Extended treatment with (1→3)(1→6)‐β‐ d ‐glucan (Botryosphaeran) reduces obesity and its comorbidities in high‐fat/high‐sugar diet‐fed rats;Cell Biochemistry and Function;2022-09-16

3. Oral administration of botryosphaeran [(1 → 3)(1 → 6)‐β‐d‐glucan] reduces inflammation through modulation of leukocytes and has limited effect on inflammatory nociception;Cell Biochemistry and Function;2022-07-05

4. Tumor cell anabolism and host tissue catabolism-energetic inefficiency during cancer cachexia;Experimental Biology and Medicine;2022-05

5. Antioxidant, anti‐inflammatory and beneficial metabolic effects of botryosphaeran [(1→3)(1→6)‐β‐ d ‐glucan] are responsible for its anti‐tumour activity in experimental non‐obese and obese rats bearing Walker‐256 tumours;Cell Biochemistry and Function;2022-02-28